October 09, 2018
Rose
A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
from Health https://ift.tt/2pKSyfo
October 09, 2018
Rose
Health, Health - The New York Times
No comments
Related Posts:
Antibody Drug to Protect the Vulnerable From Covid Goes Unused- A funding dispute with G.O.P. senators may complicate Biden’s efforts on antivirals and tests.
- The Synthetic Nicotine Loophole Fueling a Return to Teenage Vaping
- Most Women Denied Abortions by Texas Law Got Them Another Way
- A Nigerian Doctor’s Fight for Equitable Access to Vaccines
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment